(IMO) Imperial Oil - Overview
Exchange: NYSE MKT •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA4530384086
Stock:
Total Rating 60
Risk 79
Buy Signal 0.02
| Risk 5d forecast | |
|---|---|
| Volatility | 27.0% |
| Relative Tail Risk | 2.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.96 |
| Alpha | 67.80 |
| Character TTM | |
|---|---|
| Beta | 0.586 |
| Beta Downside | 1.589 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.95% |
| CAGR/Max DD | 1.54 |
EPS (Earnings per Share)
Revenue
Description: IMO Imperial Oil
Imperial Oil Limited engages in exploration, production, and sale of crude oil and natural gas in Canada. The company operates in three segments: Upstream, Downstream and Chemical segments. The Upstream segment explores and produces crude oil, natural gas, synthetic crude oil, and bitumen. The Downstream segment transports and refines crude oil; blends refined products; and distributes and markets refined products. This segment also transports crude oil production and third-party crude oil to refineries by contracted and common carrier pipelines; owns and operates refineries; maintains a distribution system to move petroleum products to market by pipeline, tanker, rail, and road transport; owns and operates fuel terminals, natural gas liquids, and products pipelines in Alberta, Manitoba, and Ontario; markets petroleum products under the Esso and Mobil brands; and sells petroleum products, including fuel, asphalt, and lubricants to industrial and transportation customers, independent marketers, resellers, and other refiners, as well as the agriculture, residential heating, and commercial markets through branded fuel and lubricant resellers. The Chemical segment manufactures and markets aliphatic solvents, plasticizer intermediates, and polyethylene resins; and markets refinery grade propylene. It also provides petrochemicals. The company was incorporated in 1880 and is headquartered in Calgary, Canada. Imperial Oil Limited operates as a subsidiary of Exxon Mobil Corporation.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 3.27b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.53 > 1.0 |
| NWC/Revenue: 3.83% < 20% (prev 4.81%; Δ -0.98% < -1%) |
| CFO/TA 0.16 > 3% & CFO 6.71b > Net Income 3.27b |
| Net Debt (3.84b) to EBITDA (6.83b): 0.56 < 3 |
| Current Ratio: 1.27 > 1.5 & < 3 |
| Outstanding Shares: last quarter (504.0m) vs 12m ago -2.42% < -2% |
| Gross Margin: 21.23% > 18% (prev 0.14%; Δ 2109 % > 0.5%) |
| Asset Turnover: 110.4% > 50% (prev 113.7%; Δ -3.31% > 0%) |
| Interest Coverage Ratio: 2126 > 6 (EBITDA TTM 6.83b / Interest Expense TTM 2.00m) |
Altman Z'' 3.76
| A: 0.04 (Total Current Assets 8.42b - Total Current Liabilities 6.62b) / Total Assets 42.31b |
| B: 0.51 (Retained Earnings 21.37b / Total Assets 42.31b) |
| C: 0.10 (EBIT TTM 4.25b / Avg Total Assets 42.62b) |
| D: 1.11 (Book Value of Equity 22.25b / Total Liabilities 20.05b) |
| Altman-Z'' Score: 3.76 = AA |
Beneish M -3.54
| DSRI: 0.79 (Receivables 4.37b/5.76b, Revenue 47.04b/48.81b) |
| GMI: 0.68 (GM 21.23% / 14.45%) |
| AQI: 1.11 (AQ_t 0.07 / AQ_t-1 0.06) |
| SGI: 0.96 (Revenue 47.04b / 48.81b) |
| TATA: -0.08 (NI 3.27b - CFO 6.71b) / TA 42.31b) |
| Beneish M-Score: -3.54 (Cap -4..+1) = AAA |
What is the price of IMO shares?
As of March 03, 2026, the stock is trading at USD 118.81 with a total of 1,046,020 shares traded.
Over the past week, the price has changed by +0.25%, over one month by +15.55%, over three months by +25.14% and over the past year by +84.16%.
Over the past week, the price has changed by +0.25%, over one month by +15.55%, over three months by +25.14% and over the past year by +84.16%.
Is IMO a buy, sell or hold?
Imperial Oil has received a consensus analysts rating of 3.22.
Therefor, it is recommend to hold IMO.
- StrongBuy: 3
- Buy: 2
- Hold: 10
- Sell: 2
- StrongSell: 1
What are the forecasts/targets for the IMO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 77.9 | -34.4% |
| Analysts Target Price | 77.9 | -34.4% |
IMO Fundamental Data Overview February 28, 2026
P/E Trailing = 24.6892
P/E Forward = 19.5313
P/S = 1.2405
P/B = 2.5298
P/EG = 0.85
Revenue TTM = 47.04b USD
EBIT TTM = 4.25b USD
EBITDA TTM = 6.83b USD
Long Term Debt = 3.45b USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 4.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 62.04b USD (58.20b + Debt 4.98b - CCE 1.14b)
Interest Coverage Ratio = 2126 (Ebit TTM 4.25b / Interest Expense TTM 2.00m)
EV/FCF = 13.19x (Enterprise Value 62.04b / FCF TTM 4.70b)
FCF Yield = 7.58% (FCF TTM 4.70b / Enterprise Value 62.04b)
FCF Margin = 10.00% (FCF TTM 4.70b / Revenue TTM 47.04b)
Net Margin = 6.94% (Net Income TTM 3.27b / Revenue TTM 47.04b)
Gross Margin = 21.23% ((Revenue TTM 47.04b - Cost of Revenue TTM 37.05b) / Revenue TTM)
Gross Margin QoQ = 41.72% (prev 11.21%)
Tobins Q-Ratio = 1.47 (Enterprise Value 62.04b / Total Assets 42.31b)
Interest Expense / Debt = -0.20% (Interest Expense -10.0m / Debt 4.98b)
Taxrate = 21.77% (136.2m / 625.5m)
NOPAT = 3.33b (EBIT 4.25b * (1 - 21.77%))
Current Ratio = 1.27 (Total Current Assets 8.42b / Total Current Liabilities 6.62b)
Debt / Equity = 0.22 (Debt 4.98b / totalStockholderEquity, last quarter 22.25b)
Debt / EBITDA = 0.56 (Net Debt 3.84b / EBITDA 6.83b)
Debt / FCF = 0.82 (Net Debt 3.84b / FCF TTM 4.70b)
Total Stockholder Equity = 22.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.66% (Net Income 3.27b / Total Assets 42.31b)
RoE = 14.73% (Net Income TTM 3.27b / Total Stockholder Equity 22.17b)
RoCE = 16.60% (EBIT 4.25b / Capital Employed (Equity 22.17b + L.T.Debt 3.45b))
RoIC = 11.95% (NOPAT 3.33b / Invested Capital 27.83b)
WACC = 7.42% (E(58.20b)/V(63.18b) * Re(8.07%) + D(4.98b)/V(63.18b) * Rd(-0.20%) * (1-Tc(0.22)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.93%
[DCF] Terminal Value 81.15% ; FCFF base≈4.47b ; Y1≈4.78b ; Y5≈5.78b
[DCF] Fair Price = 226.4 (EV 113.34b - Net Debt 3.84b = Equity 109.51b / Shares 483.6m; r=7.42% [WACC]; 5y FCF grow 7.74% → 2.90% )
EPS Correlation: -31.01 | EPS CAGR: 3.21% | SUE: 0.16 | # QB: 0
Revenue Correlation: -51.19 | Revenue CAGR: 1.20% | SUE: -0.46 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.55 | Chg7d=-0.011 | Chg30d=-0.123 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=6.87 | Chg7d=-0.028 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=-19.5% | Growth Revenue=+7.3%
EPS next Year (2027-12-31): EPS=7.58 | Chg7d=-0.060 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+10.4% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.0% (Discount Rate 8.1% - Earnings Yield 4.1%)
[Growth] Growth Spread = -29.4% (Analyst -25.4% - Implied 4.0%)
P/E Forward = 19.5313
P/S = 1.2405
P/B = 2.5298
P/EG = 0.85
Revenue TTM = 47.04b USD
EBIT TTM = 4.25b USD
EBITDA TTM = 6.83b USD
Long Term Debt = 3.45b USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 4.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.84b USD (from netDebt column, last quarter)
Enterprise Value = 62.04b USD (58.20b + Debt 4.98b - CCE 1.14b)
Interest Coverage Ratio = 2126 (Ebit TTM 4.25b / Interest Expense TTM 2.00m)
EV/FCF = 13.19x (Enterprise Value 62.04b / FCF TTM 4.70b)
FCF Yield = 7.58% (FCF TTM 4.70b / Enterprise Value 62.04b)
FCF Margin = 10.00% (FCF TTM 4.70b / Revenue TTM 47.04b)
Net Margin = 6.94% (Net Income TTM 3.27b / Revenue TTM 47.04b)
Gross Margin = 21.23% ((Revenue TTM 47.04b - Cost of Revenue TTM 37.05b) / Revenue TTM)
Gross Margin QoQ = 41.72% (prev 11.21%)
Tobins Q-Ratio = 1.47 (Enterprise Value 62.04b / Total Assets 42.31b)
Interest Expense / Debt = -0.20% (Interest Expense -10.0m / Debt 4.98b)
Taxrate = 21.77% (136.2m / 625.5m)
NOPAT = 3.33b (EBIT 4.25b * (1 - 21.77%))
Current Ratio = 1.27 (Total Current Assets 8.42b / Total Current Liabilities 6.62b)
Debt / Equity = 0.22 (Debt 4.98b / totalStockholderEquity, last quarter 22.25b)
Debt / EBITDA = 0.56 (Net Debt 3.84b / EBITDA 6.83b)
Debt / FCF = 0.82 (Net Debt 3.84b / FCF TTM 4.70b)
Total Stockholder Equity = 22.17b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.66% (Net Income 3.27b / Total Assets 42.31b)
RoE = 14.73% (Net Income TTM 3.27b / Total Stockholder Equity 22.17b)
RoCE = 16.60% (EBIT 4.25b / Capital Employed (Equity 22.17b + L.T.Debt 3.45b))
RoIC = 11.95% (NOPAT 3.33b / Invested Capital 27.83b)
WACC = 7.42% (E(58.20b)/V(63.18b) * Re(8.07%) + D(4.98b)/V(63.18b) * Rd(-0.20%) * (1-Tc(0.22)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.93%
[DCF] Terminal Value 81.15% ; FCFF base≈4.47b ; Y1≈4.78b ; Y5≈5.78b
[DCF] Fair Price = 226.4 (EV 113.34b - Net Debt 3.84b = Equity 109.51b / Shares 483.6m; r=7.42% [WACC]; 5y FCF grow 7.74% → 2.90% )
EPS Correlation: -31.01 | EPS CAGR: 3.21% | SUE: 0.16 | # QB: 0
Revenue Correlation: -51.19 | Revenue CAGR: 1.20% | SUE: -0.46 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.55 | Chg7d=-0.011 | Chg30d=-0.123 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=6.87 | Chg7d=-0.028 | Chg30d=-0.043 | Revisions Net=-1 | Growth EPS=-19.5% | Growth Revenue=+7.3%
EPS next Year (2027-12-31): EPS=7.58 | Chg7d=-0.060 | Chg30d=-0.010 | Revisions Net=-2 | Growth EPS=+10.4% | Growth Revenue=+3.4%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.0% (Discount Rate 8.1% - Earnings Yield 4.1%)
[Growth] Growth Spread = -29.4% (Analyst -25.4% - Implied 4.0%)